You are here » Home » Companies » Company Overview » Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd.

BSE: 500420	Sector: Health care
NSE: TORNTPHARM	ISIN Code: INE685A01028

BSE 10:15 | 25 Sep

2646.70

-2.30
(-0.09%)

OPEN

2681.50

HIGH

2693.30

LOW

2635.85

NSE 10:09 | 25 Sep

2639.75

-10.50
(-0.40%)

OPEN

2673.90

HIGH

2695.00

LOW

2634.85

Add to Watchlist | Add to Portfolio

OPEN	2681.50
PREVIOUS CLOSE	2649.00
VOLUME	1226
52-Week high	3040.00
52-Week low	1554.65
P/E	44.17
Mkt Cap.(Rs cr)	44,787
Buy Price	2641.85
Buy Qty	5.00
Sell Price	2645.80
Sell Qty	15.00

OPEN	2681.50
CLOSE	2649.00
VOLUME	1226
52-Week high	3040.00
52-Week low	1554.65
P/E	44.17
Mkt Cap.(Rs cr)	44,787
Buy Price	2641.85
Buy Qty	5.00
Sell Price	2645.80
Sell Qty	15.00

Click here for interactive graph

Torrent Pharmaceuticals Ltd. (TORNTPHARM) - Latest News & Headlines

Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks

12.01 pm | 17 Sep 2020 | Business Standard

The next upside for Nifty Pharma is located above the resistance of 12,100 levels.
Nifty outlook & stock calls by Anand Rathi: Buy TCS, Torrent Pharma

8.21 am | 4 Sep 2020 | Business Standard

TCS' stock has provided a breakout from a descending triangle pattern on the daily chart
Nifty may resume downtrend if it breaks below 11,350: HDFC Securities

8.12 am | 2 Sep 2020 | Business Standard

The recent high of 11,794 would continue to act as strong resistance for the Nifty
Robust performance of domestic biz to help Torrent Pharma outperform peers

9.54 pm | 31 Jul 2020 | Business Standard

Chronic-heavy portfolio, pharma market recovery boost shares
Torrent Pharma leaps 10%, nears 52-wk high as Q1 net profit jumps 49% YoY

9.58 am | 31 Jul 2020 | Business Standard

In terms of markets, while its India revenues grew marginally by 2% on a year-on-year (YoY) basis to Rs 925 crore, up from Rs 907 crore in Q1 of FY20,...
Torrent Pharma Q1 PBT up 44% to Rs 402 cr, income rises marginally

12.44 am | 31 Jul 2020 | Business Standard

Domestic and US market revenues more or less flat, 20% drop in Brazilian revenues
Trading ideas by Religare Broking: Buy IGL, Torrent Pharmaceuticals

8.19 am | 15 Jul 2020 | Business Standard

IGL has tested the major support zone of the long-term moving average (200 EMA) on the daily chart of late
Pharma shares in focus: Cipla, Aurobindo Pharma hit 52-week high

2.03 pm | 29 May 2020 | Business Standard

Dr Reddy's, Divis Labs, Biocon, JB Chemicals, Caplin Point Lab, Aarti Drugs, Indoco Remedies, RPG Lifesciences and Glenmark Pharma were up in the rang...
Torrent Pharma slips 6% on profit-booking; outlook remains a concern

12.02 pm | 27 May 2020 | Business Standard

Unlike peers, Torrent Pharma guided for a relatively moderate outlook across geographies, note analysts at Emkay Global Financial Services.
Torrent Pharma posts Q4FY20 PBT of Rs 293 cr, consolidated revenue up 4.69%

8.28 pm | 26 May 2020 | Business Standard

The company saw its total consolidated revenue in Q4FY20 at Rs 1961 crore, up by a marginal 4.69 per cent over Rs 1873 crore in Q4FY19
Sensex slips 477 pts from day's high, ends 63 pts lower; IT stocks decline

4.08 pm | 26 May 2020 | Business Standard

All that happened in the markets today
BSE Healthcare index hits 52-week high, zooms 36% from March low

10.18 am | 13 Apr 2020 | Business Standard

Dr Reddy's Laboratories, Cipla, and seven other frontline pharma stocks have hit their respective 52-week highs in the past one week
Pharma stocks rally; Nifty Pharma index surges 10%, Ipca Labs hits new high

12.06 pm | 7 Apr 2020 | Business Standard

Torrent Pharmaceuticals also rose 15 per cent to a fresh 52-week high of Rs 2,380
Torrent Pharma says promoters haven't pledged equity, NSE action not needed

2.04 pm | 5 Apr 2020 | Business Standard

Torrent said a pledge of shares is a security interest in favour of lenders and can be enforced by sale of such shares in event of default